The following are documented considerations from the research and safety literature, framed for research handling not medical advice and not an exhaustive list
Rybelsus is formulated with an absorption enhancer to prevent breakdown in the GI tract
5-Amino-1MQs confirmed high selectivity documented not to inhibit related SAM-dependent methyltransferases or NAD+ salvage pathway enzymes makes it the most validated small-molecule NNMT research tool currently available, and ensures that experimental findings can be reliably attributed to NNMT inhibition rather than off-target effects
doi: 10.1093/toxsci/kfu216
What they found: Visible skin pigmentation in all subjects after 5 to 7 injections Pigmentation was strongest in exposed areas (face, neck, hands), suggesting synergy with low UV exposure Nausea in 90 % of subjects in initial doses, gradually subsiding Spontaneous erections in all male subjects , an unexpected finding Loss of appetite with average weight loss of 1.2 kg over 10 days Mild increase in blood pressure in the first hour after injection Why it matters: This was the first published clinical study of Melanotan II in humans
doi: 10.1089/thy.2012.0579 172 ZickerSSchoenherrB
